Somatostatinoma: Beyond neurofibromatosis type 1

F Sandru, M Carsote, A Valea… - Experimental and …, 2020 - spandidos-publications.com
Somatostatinoma is a tumour mainly originating from pancreas or duodenum; overall with an
incidence of 1/40 million persons. We introduce a narrative review of literature of …

Duodenal somatostatinoma presenting as obstructive jaundice with the coexistence of a gastrointestinal stromal tumour in neurofibromatosis type 1: a case with …

S Thavaraputta, S Graham, AMR Mejia… - … Case Reports CP, 2019 - casereports.bmj.com
Somatostatinomas are rare neuroendocrine tumours, mostly located in the pancreas or
duodenum, with an estimated incidence of 1 in 40 million. Duodenal somatostatinomas …

Idelalisib induced CMV gastrointestinal disease: the need for vigilance with novel therapies

L Goldring, B Kumar, TE Gan, MSY Low - Pathology, 2017 - pathologyjournal.rcpa.edu.au
6. Koc O, Duzkoylu Y, Sari YS, et al. Duodenal somatostatinoma: a case report and review of
the literature. J Med Case Rep 2013; 7: 115. 7. Klöppel G. Update of WHO classification of …

Somatostatinoma of the Ampulla: An incidental postoperative finding following colorectal cancer resection

JB French, R Pawa - ACG Case Reports Journal, 2016 - journals.lww.com
Somatostatinoma of the gastrointestinal tract is a rare finding, especially arising from the
ampulla of Vater. We present a man recently diagnosed with rectal adenocarcinoma who …

[PDF][PDF] Rare case of primary duodenal somatostatinoma

A Subramaniam, A Natesan… - Indian Journal of …, 2019 - mansapublishers.com
Neuroendocrine tumors develop from any part of the gastrointestinal tract. Duodenal
neuroendocrine tumors constitute only 2.6% of all neuroendocrine tumors …

[HTML][HTML] Case Report: Duodenal somatostatinoma presenting as obstructive jaundice with the coexistence of a gastrointestinal stromal tumour in neurofibromatosis …

S Thavaraputta, S Graham, AMR Mejia… - BMJ Case …, 2019 - ncbi.nlm.nih.gov
Somatostatinomas are rare neuroendocrine tumours, mostly located in the pancreas or
duodenum, with an estimated incidence of 1 in 40 million. Duodenal somatostatinomas …

[PDF][PDF] Duodenal neuroendocrine tumors (d-neTs): challenges in diagnosis and treatment

M Brozić, D Kust, PP Ovčariček, VG Nenadić, D Marjan… - researchgate.net
Duodenal neuroendocrine tumors (d-NETs) represent 2% of all gastroenteropancreatic
neuroendocrine neoplasms. Approximately 40 to 60% of patients at the time of diagnosis …

[PDF][PDF] Zaburzenia gospodarki węglowodanowej w endokrynopatiach.

T Rudzińska, A Ramotowska… - Pediatric …, 2016 - endokrynologiapediatryczna.pl
Hiperglikemia i/lub cukrzyca poza dobrze znaną izolowaną postacią może występować
również w przebiegu wielu innych endokrynopatii. Według Polskiego Towarzystwa …

[PDF][PDF] A Rare Case of Duodenal Somatostatinoma

J Sankpal, S Shetty, V Tilwani, P Turkar - researchgate.net
Somatostatinomas are the rarest of pancreatic tumours and can arise in pancreas and
duodenum. Duodenal somatostatinomas are less common and are distinguished from their …

[PDF][PDF] Long-Term Survival of a Patient with Jejunal Somatostatin-Producing Tumour and Liver Metastases

PI Beato-Víbora, R Rodríguez-López… - 2014 - ibimapublishing.com
Extrapancreatic somatostatinomas are uncommon neuroendocrine tumours. Information
related to its long-term prognosis is scarce. The prognosis of patients with advanced …